David Abrams
Abrams Capital Management
David Abrams Celgene Corp stake
total: 84
Abrams Capital Management CELG trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2019 Q1
- Held for:
- 3 quarters
- Latest activity:
- 2019 Q4
According to 2026 Q1 report, David Abrams doesn't hold any Celgene Corp (CELG) shares. To date, the estimated cost basis is nearly $94.34 for "buy" trades and estimated average "sell" price is $99.3. Abrams Capital Management first purchased CELG in 2019 Q1, initially acquiring about 6.75M shares. Since the initial investment in Celgene Corp (CELG), Abrams Capital Management has made 1 more transaction.
When did David Abrams sell Celgene Corp (CELG)?
David Abrams sold off the entire Celgene Corp (CELG) position in 2019 Q4.
When did David Abrams buy Celgene Corp (CELG)?
David Abrams first invested in Celgene Corp (CELG) in 2019 Q1 at the reported quarter-end price of $94.34 per share.
What's the cost basis of Abrams Capital Management's CELG stake?
The estimated cost basis for Celgene Corp (CELG) stake is around $94.34 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $94.34
- Weighted AVG sell price:
- $99.30
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.